Home › BioMérieux Investigating Sepsis Biomarkers in Public, Private Research Collaboration

BioMérieux Investigating Sepsis Biomarkers in Public, Private Research Collaboration

Oct 10, 2016

NEW YORK (GenomeWeb) – BioMérieux is collaborating with Bioaster, a French accelerator of microbiology technology innovation; ESPCI, the College of Physics and Industrial Chemistry of the city of Paris; GSK; HCL, the Hospices Civils de Lyon; and Sanofi to identify and validate new biomarkers aimed at diagnosing patients that present with high risk of sepsis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

What's Popular?

In Molecular Diagnostics

  1. Cancer Genetics Cancels Planned Merger With NovellusDx

  2. Mobidiag, Autobio Diagnostics to Form Joint Venture in China

  3. Black Women With Breast Cancer Fare Worse, TAILORx Analysis Confirms at SABCS

    Premium

  4. Guardant Health to Develop Blood-Based CDx for AstraZeneca Drugs

  5. Exosome Diagnostics Suing Former Employee for IP Theft

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.